Amicus Therapeutics, Inc. (DELISTED) (FOLD:DL)
14.49
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
Amicus Therapeutics 1 Year Total Returns (Daily) : 137.9% for May 7, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 07, 2026 | 137.9% |
| May 06, 2026 | 134.1% |
| May 05, 2026 | 121.9% |
| May 04, 2026 | 117.2% |
| May 01, 2026 | 116.9% |
| April 30, 2026 | 88.67% |
| April 29, 2026 | 92.69% |
| April 28, 2026 | 96.08% |
| April 27, 2026 | 97.14% |
| April 24, 2026 | 101.2% |
| April 23, 2026 | 103.7% |
| April 22, 2026 | 109.3% |
| April 21, 2026 | 115.5% |
| April 20, 2026 | 111.7% |
| April 17, 2026 | 111.7% |
| April 16, 2026 | 115.7% |
| April 15, 2026 | 109.6% |
| April 14, 2026 | 115.2% |
| April 13, 2026 | 123.1% |
| April 10, 2026 | 122.1% |
| April 09, 2026 | 110.0% |
| April 08, 2026 | 115.2% |
| April 07, 2026 | 102.4% |
| April 06, 2026 | 92.67% |
| April 02, 2026 | 80.73% |
| Date | Value |
|---|---|
| April 01, 2026 | 81.64% |
| March 31, 2026 | 77.21% |
| March 30, 2026 | 71.17% |
| March 27, 2026 | 67.75% |
| March 26, 2026 | 69.37% |
| March 25, 2026 | 67.40% |
| March 24, 2026 | 65.82% |
| March 23, 2026 | 60.13% |
| March 20, 2026 | 58.92% |
| March 19, 2026 | 56.30% |
| March 18, 2026 | 60.02% |
| March 17, 2026 | 57.57% |
| March 16, 2026 | 61.46% |
| March 13, 2026 | 63.11% |
| March 12, 2026 | 61.64% |
| March 11, 2026 | 61.82% |
| March 10, 2026 | 66.40% |
| March 09, 2026 | 62.19% |
| March 06, 2026 | 58.98% |
| March 05, 2026 | 56.61% |
| March 04, 2026 | 57.30% |
| March 03, 2026 | 57.06% |
| March 02, 2026 | 51.32% |
| February 27, 2026 | 56.37% |
| February 26, 2026 | 58.69% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| BioMarin Pharmaceutical, Inc. | 14.20% |
| Insmed, Inc. | -5.89% |
| Ligand Pharmaceuticals, Inc. | 80.18% |
| PTC Therapeutics, Inc. | 46.97% |
| Establishment Labs Holdings, Inc. | 73.49% |